NCT01663168 arm group a6af99a187ef0e752b5340dc196a8edf [clinicaltrials_resource:NCT01663168/arm-group/a6af99a187ef0e752b5340dc196a8edf]
arm group [clinicaltrials_vocabulary:arm-group]
NCT01663168 arm group a6af99a187ef0e752b5340dc196a8edf [clinicaltrials_resource:NCT01663168/arm-group/a6af99a187ef0e752b5340dc196a8edf]
Bio2RDF identifier
NCT01663168/arm-group/a6af99a187ef0e752b5340dc196a8edf
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltri ...... af99a187ef0e752b5340dc196a8edf
description [clinicaltrials_vocabulary:description]
Rifabutin 150mg tablet daily i ...... ion of TB treatment (24 weeks)
identifier
clinicaltrials_resource:NCT01663168/arm-group/a6af99a187ef0e752b5340dc196a8edf
title
NCT01663168 arm group a6af99a187ef0e752b5340dc196a8edf
@en
type
label
NCT01663168 arm group a6af99a1 ...... f99a187ef0e752b5340dc196a8edf]
@en